Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza A virus H7N1 Antigen (H7N1 Antigen)
- Target
- H7N1 Antigen
- Molecular classification
- Viral protein, Glycoprotein, Hemagglutinin, Neuraminidase, Antigen
01
Overview
The Influenza virus H7N1 antigen refers to the surface glycoproteins, primarily hemagglutinin (HA) and neuraminidase (NA), of the Influenza A virus subtype H7N1. It is a key target for immune responses, diagnostics, and vaccine development. H7N1 is primarily an avian influenza virus but can infect mammals. Vaccines targeting H7N1 induce antibodies against both head and stalk domains of HA, potentially offering broader protection. Key adaptive mutations in internal genes can facilitate airborne transmission among mammals.
- Other names
- H7N1 HemagglutininH7N1 NeuraminidaseInfluenza A/H7N1H7N1 HAH7N1 NA
02
Mechanism of action
Vaccines induce neutralizing antibodies against HA and NA. Neuraminidase inhibitors block viral release from infected cells.
03
Biological functions
Viral entryViral releaseImmune response elicitationAntigenic targetReceptor binding
04
Disease associations
InfectionAvian influenzaPotential zoonotic diseaseEncephalopathy
05
Safety considerations
Potential for antigenic drift and shiftRisk of vaccine-associated adverse eventsPotential for zoonotic transmissionEmergence of drug resistance
06
Interacting drugs
H7N1 vaccines
1 more in the full profile.
07
Biomarkers
Antibody titers against H7N1 HAAntibody titers against H7N1 NAViral load
Beyond the preview
Go deeper on Influenza A virus H7N1 Antigen (H7N1 Antigen).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Influenza A virus H7N1 Antigen (H7N1 Antigen).